Risk factor model to predict venous thromboembolism in hospitalized medical patients

Journal of Hospital Medicine

Volumn 6, Issue 4, 2011, Pages 202-209

  Rothberg, Michael B ^a,b   Lindenauer, Peter K ^a,b   Lahti, Maureen ^c   Pekow, Penelope S ^a,c   Selker, Harry P ^d,e  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID;

ACCREDITATION; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CANCER CHEMOTHERAPY; CANCER THERAPY; CENTRAL VENOUS CATHETER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONGESTIVE HEART FAILURE; DECUBITUS; DIABETES MELLITUS; DIAGNOSTIC TEST; ENTERITIS; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; IMMOBILIZATION; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYELOPROLIFERATIVE DISORDER; NEOPLASM; NEPHROTIC SYNDROME; OBESITY; OUTCOME ASSESSMENT; PARALYSIS; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEPTICEMIA; SMOKING; STATISTICAL MODEL; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT INDICATION; UNITED STATES; URINARY CATHETER; URINARY TRACT INFECTION; VALIDATION STUDY; VARICOSIS; VENOUS THROMBOEMBOLISM;

EID: 79953750695     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.888     Document Type: Article

References (25)

1. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999; 341(11): 793-800.
2. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest. 2008; 133(6 suppl): 381S-453S.
3. Schuurman B, den Heijer M, Nijs AM. Thrombosis prophylaxis in hospitalised medical patients: does prophylaxis in all patients make sense? Neth J Med. 2000; 56(5): 171-176.
4. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167(14): 1476-1486.
5. The Joint Commission on the Accreditation of Healthcare Organizations. Venous thromboembolism (VTE) core measure set. Available at: Accessed June 1, 2009.
6. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001; 38(2 suppl 5): 12-19.
7. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost. 2005; 94(4): 750-759.
8. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(3 suppl): 338S-400S.
9. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36(1): 8-27.
10. Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data. Is it valid? Med Care. 2000; 38(8): 785-795.
11. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004; 164(9): 963-968.
12. Dunn AS, Brenner A, Halm EA. The magnitude of an iatrogenic disorder: a systematic review of the incidence of venous thromboembolism for general medical inpatients. Thromb Haemost. 2006; 95(5): 758-762.
13. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004; 110(7): 874-879.
14. Gardlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet. 1996; 347(9012): 1357-1361.
15. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007; 146(4): 278-288.
16. National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism: Policy, Preferred Practices, and Initial Performance Measures. Washington, DC; 2006.
17. Weill-Engerer S, Meaume S, Lahlou A, et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study. J Am Geriatr Soc. 2004; 52(8): 1299-1304.
18. Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost. 2004; 2(12): 2156-2161.
19. Arcelus JI, Candocia S, Traverso CI, Fabrega F, Caprini JA, Hasty JH. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost. 1991; 17(suppl 3): 313-318.
20. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991; 151(5): 933-938.
21. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992; 305(6853): 567-574.
22. Maynard G, Stein J. Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement. AHRQ Publication No. 08-0075. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
23. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005; 352(10): 969-977.
24. Bergmann JF, Segrestaa JM, Caulin C. Prophylaxis against venous thromboembolism. BMJ. 1992; 305(6862): 1156.
25. Ageno W, Dentali F. Prevention of in-hospital VTE: why can't we do better? Lancet. 2008; 371(9610): 361-362.